Nochur Sara
Insider CIK 1852196 · MRNS Director · DBTX Director · CTY Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CTY CITY THERAPEUTICS, INC. | A Award deriv | 2026-10-15 | 2026-10-19 | 22,649 | — | $0 | 22,649 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award deriv | 2024-06-18 | 2024-06-20 | 10,450 | — | $0 | 10,450 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award | 2024-06-18 | 2024-06-20 | 2,300 | — | $0 | 13,250 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award deriv | 2024-01-18 | 2024-01-19 | 20,900 | — | $0 | 20,900 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award | 2024-01-18 | 2024-01-19 | 4,600 | — | $0 | 10,950 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | D To issuer deriv | 2023-09-25 | 2023-09-25 | 10,000 | — | $0 | 0 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | D To issuer deriv | 2023-09-25 | 2023-09-25 | 20,000 | — | $0 | 0 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | D To issuer deriv | 2023-09-25 | 2023-09-25 | 5,000 | — | $0 | 0 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | D To issuer | 2023-09-25 | 2023-09-25 | 5,000 | — | $0 | 0 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | A Award deriv | 2023-06-13 | 2023-06-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | A Award | 2023-06-13 | 2023-06-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award deriv | 2023-01-26 | 2023-01-30 | 16,200 | — | $0 | 16,200 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award | 2023-01-26 | 2023-01-30 | 3,600 | — | $0 | 6,350 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | A Award deriv | 2022-06-17 | 2022-06-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2022-02-04 | 2022-02-07 | 12,375 | — | $0 | 12,375 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award | 2022-02-04 | 2022-02-07 | 2,750 | — | $0 | 2,750 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | A Award deriv | 2021-12-03 | 2021-12-06 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2021-03-22 | 2021-03-24 | 33,000 | — | $0 | 33,000 | SEC↗ |